HoLEP vs TURP vs UroLift | What Each Procedure Actually Does

Why This Matters

Durability is the real story.

Procedures that completely remove the obstructing tissue have lower retreatment rates than procedures that partially remove it, which in turn have lower rates than procedures that only displace it. This is not a marketing point — it's physics. If you leave obstructing tissue behind, it continues to grow, and the problem comes back.

Retreatment rates (approximate, published ranges)

Percentage of patients needing a repeat procedure for their BPH within 10–15 years

HoLEP

<5%

TURP

10–15%

UroLift

~20%+

What this means for how you choose

The three procedures aren't really competing to do the same job — they're actually different trade-offs for different patients. Choosing well means matching the procedure to your priorities.

If durability is your top priority

HoLEP is the clear answer. Over a 15-year horizon, fewer than 1 in 20 HoLEP patients need any further BPH intervention. The adenoma is gone; there's nothing left to regrow. This is the standard choice for patients who want one procedure and done.

If you want something fast with essentially no recovery

UroLift is appealing. No cutting, no catheter in many cases, same-day discharge. The trade-off: about 1 in 5 patients need something else within a decade. For younger patients with small prostates, no middle lobe, and a strong preference to preserve sexual function exactly as it is (UroLift has very low rates of retrograde ejaculation), it's a reasonable first step. Just know it may not be your last.

If TURP was recommended to you

TURP was the standard of care for 50 years and it's a very good procedure in the hands of an experienced surgeon. For moderate-sized prostates (40–70g), TURP still performs well. For prostates over 80g, the data favors HoLEP meaningfully. If you've been offered TURP for a large prostate, it's worth getting a second opinion from a HoLEP surgeon before committing.

Other factors that may shift the decision

Prostate size. Above about 80g, HoLEP becomes the clear best option. Above 150g, it's essentially the only endoscopic option.
Blood thinners. HoLEP has the safest profile in patients who can't stop anticoagulation.
Age and life expectancy. Younger patients (where durability matters for decades) tilt toward HoLEP. Older patients with limited life expectancy may do fine with any option that fits their preferences.
Urinary retention. HoLEP has the best data for restoring urination in men who've been catheter-dependent. UroLift often isn't appropriate for this situation. See the catheter-dependent guide.
Middle lobe anatomy. If your prostate has a prominent middle lobe, UroLift is not a good fit. HoLEP handles this anatomy well.

What we don't see in these diagrams

The animations above show the mechanical difference between procedures, but there's more to the story:

Sexual side effects — rates of retrograde ejaculation and erectile changes differ between procedures. UroLift preserves antegrade ejaculation better than HoLEP or TURP. HoLEP preserves erectile function as well as or better than TURP.
Continence — temporary stress incontinence is most common after HoLEP (usually resolves by 3 months) and less common after UroLift.
Bleeding risk — HoLEP has the lowest bleeding risk of the three, particularly in patients on anticoagulants.
Surgeon experience — for HoLEP especially, surgeon volume strongly predicts outcomes. Whoever does your procedure should have done hundreds of them.

"All three of these procedures have a place in modern BPH care. The question isn't which is 'best' in the abstract — it's which matches your anatomy, priorities, and timeline."

— Dr. Brandon Childs

HoLEP vs. TURP vs. UroLift — what each one actually does.

Same prostate. Three different procedures.